We are live on ! Find out more
VMD icon

Viemed Healthcare

82 hedge funds and large institutions have $119M invested in Viemed Healthcare in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

6% more funds holding

Funds holding: 7782 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2.58% less ownership

Funds ownership: 56.78%54.21% (-2.6%)

11% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 27

26% less capital invested

Capital invested by funds: $161M → $119M (-$41.8M)

Holders
82
Holders Change
+5
Holders Change %
+6.49%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
24
Reduced
27
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
1
Thrivent Financial for Lutherans
Minnesota
$20.1M +$345K +53,037 +1%
BlackRock
2
BlackRock
New York
$12.3M -$73.1K -11,230 -0.5%
CSC
3
Cove Street Capital
California
$9.16M -$712K -109,474 -6%
NCM
4
Nantahala Capital Management
Connecticut
$7.95M -$1.74M -267,395 -16%
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.89M +$1.25M +192,143 +16%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$7.41M -$1.5M -230,812 -15%
MFP
7
Michael F. Price
$5.55M +$1.04M +159,624 +19%
Goldman Sachs
8
Goldman Sachs
New York
$5.27M -$1.05M -161,685 -15%
AIC
9
AWM Investment Company
New York
$4.05M -$2.32M -356,167 -33%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$3.62M -$1.77M -272,125 -29%
VCM
11
Voce Capital Management
California
$3.38M +$1.04M +159,643 +35%
State Street
12
State Street
Massachusetts
$2.88M +$12K +1,851 +0.4%
Renaissance Technologies
13
Renaissance Technologies
New York
$2.52M +$208K +32,000 +8%
Russell Investments Group
14
Russell Investments Group
United Kingdom
$2.48M +$1.65M +253,097 +130%
RHJA
15
Rice Hall James & Associates
California
$2.41M -$615K -94,494 -18%
RA
16
Raffles Associates
New York
$2.23M -$163K -25,000 -6%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.73M +$56.9K +8,743 +3%
Wells Fargo
18
Wells Fargo
California
$1.45M +$483K +74,257 +40%
Northern Trust
19
Northern Trust
Illinois
$1.41M -$65.3K -10,031 -4%
Los Angeles Capital Management
20
Los Angeles Capital Management
California
$1.15M -$118K -18,210 -8%
ACA
21
Anchor Capital Advisors
Massachusetts
$990K -$1.41M -216,123 -55%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$981K +$205K +31,556 +22%
FFH
23
Fairfax Financial Holdings
Ontario, Canada
$830K
Millennium Management
24
Millennium Management
New York
$822K +$963K +147,933 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$637K +$44.3K +6,814 +6%

VMD Hedge Fund Activity: Q3 2021 in Review

82 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2021, worth a combined $119M — down 26% from $161M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new VMD positions and 9 closed out — a net gain of 5 holders — while 24 added to existing stakes and 27 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $1.65M. The largest seller was AWM Investment Company, cutting an estimated $2.32M.

  • 82 institutional investors held Viemed Healthcare (VMD) as of Q3 2021, up from 77 in Q2 2021.
  • Funds reported $119M of Viemed Healthcare stock for Q3 2021, down 26% quarter-over-quarter.
  • 14 funds opened new Viemed Healthcare positions in Q3 2021 and 9 closed out, a net change of +5 holders.
  • The largest Viemed Healthcare buyer in Q3 2021 was Russell Investments Group, an estimated $1.65M added.
  • The largest Viemed Healthcare seller in Q3 2021 was AWM Investment Company, an estimated $2.32M sold.

Based on aggregated 13F filings for Q3 2021.